We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Parathyroid Hormone Test May Be Used During Surgery

By HospiMedica staff writers
Posted on 29 Aug 2007
A nine-minute parathyroid hormone (PTH) test can be used during parathyroid surgery. More...


The test provides quantitative results on the amount of parathyroid hormone in human serum and plasma to diagnose hypercalcemia and hypocalcemia, which helps physicians diagnose parathyroid dysfunction.

Developed by Roche Diagnostics (Indianapolis, IN, USA), the nine-minute PTH test is performed on Roche's Elecsys 1010 and 2010 systems and cobas e 411 analyzer. It has received clearance from the US Food and Drug Administration (FDA) for use during parathyroid surgery. This will provide faster results for surgeons, which should result in shorter surgeries for patients.

Surgeons use the test to establish a PTH baseline on patients with parathyroid adenoma that can cause their parathyroids to malfunction. The test will now be used during surgery at different intervals after the gland is removed to determine whether all the adenoma has been removed and the gland is back to normal function.

Dr. Herbert Chen, chief of endocrine surgery for the University of Wisconsin (Madison, WI, USA), determined that intraoperative parathyroid hormone measurement improves cure rates in patients undergoing minimally invasive parathyroidectomies because it allows surgeons to recognize and address additional hyperfunctioning parathyroids during surgery that were missed by preoperative imaging.

Dr. Gerard Doherty, an endocrine surgeon at the University of Michigan (Ann Arbor, MI, USA), estimates the test will help him cut at least five to eight minutes off the length of a typical surgery, and much more time from the surgeries of the patients with more than one impacted gland and the surgeries of the slow degrader patients whose PTH levels fall slower after their adenoma is removed.

This test can help patients, surgeons and hospital administrators, said Andy Thomson, senior vice president of Centralized Diagnostics, Roche Diagnostics. The reduced test time--in most cases less than half the time of competing tests--means surgeons spend less time waiting for test results, allowing them to get their patients out of the operating room faster.


Related Links:
Roche Diagnostics
University of Wisconsin
University of Michigan

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.